PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 206 filers reported holding PDL BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $252,000 | -15.4% | 89,207 | -3.0% | 0.00% | – |
Q4 2019 | $298,000 | +79.5% | 91,923 | +19.8% | 0.00% | – |
Q3 2019 | $166,000 | -26.2% | 76,716 | +7.2% | 0.00% | – |
Q2 2019 | $225,000 | -14.8% | 71,564 | +0.8% | 0.00% | – |
Q1 2019 | $264,000 | +26300.0% | 70,979 | +9982.2% | 0.00% | – |
Q2 2018 | $1,000 | -50.0% | 704 | 0.0% | 0.00% | – |
Q1 2018 | $2,000 | +100.0% | 704 | +245.1% | 0.00% | – |
Q4 2017 | $1,000 | -98.0% | 204 | -98.6% | 0.00% | – |
Q3 2017 | $49,000 | +2350.0% | 14,283 | +1928.8% | 0.00% | – |
Q2 2017 | $2,000 | – | 704 | +245.1% | 0.00% | – |
Q1 2017 | $0 | -100.0% | 204 | -96.4% | 0.00% | – |
Q4 2016 | $11,000 | -50.0% | 5,617 | -16.3% | 0.00% | – |
Q3 2016 | $22,000 | 0.0% | 6,712 | -5.3% | 0.00% | – |
Q2 2016 | $22,000 | -53.2% | 7,088 | -50.0% | 0.00% | – |
Q1 2016 | $47,000 | -9.6% | 14,184 | -3.9% | 0.00% | – |
Q4 2015 | $52,000 | -11.9% | 14,765 | +26.3% | 0.00% | – |
Q3 2015 | $59,000 | +1866.7% | 11,686 | +2496.9% | 0.00% | – |
Q4 2014 | $3,000 | 0.0% | 450 | 0.0% | 0.00% | – |
Q3 2014 | $3,000 | -78.6% | 450 | -67.8% | 0.00% | – |
Q2 2014 | $14,000 | +366.7% | 1,396 | +341.8% | 0.00% | – |
Q4 2013 | $3,000 | 0.0% | 316 | 0.0% | 0.00% | – |
Q3 2013 | $3,000 | -57.1% | 316 | -64.2% | 0.00% | – |
Q2 2013 | $7,000 | – | 883 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |